QDEL Stock Analysis: Buy, Sell, or Hold?
QDEL - QuidelOrtho Corporation Common Stock
$27.17
-0.24 (-0.88%)
▼
BUY
HIGH Confidence
Last Updated: January 30, 2026
Earnings: Feb 11, 2026
11d
Get Alerted When QDEL Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: QDEL shows strong fundamentals and good volume confirmation. Solid entry point despite oversold pricing.
✅ BUY SIGNAL: QDEL shows strong fundamentals and good volume confirmation. Solid entry point despite oversold pricing.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$51.58
Based on 12.3% avg growth
INTRINSIC VALUE TODAY
$32.02
15.2% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 11.6x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: QDEL is currently trading at $27.17, which is considered oversold relative to its 30-day fair value range of $27.98 to $33.01. The stock's valuation (Forward PE: 10.9) is in line with its historical norms (11.6). Remarkably, the market is currently pricing in an annual earnings decline of 2.1% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, QDEL is in a strong downtrend. Immediate support is located at $25.81, while resistance sits at $35.58.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. In the options market, Implied Volatility is low (6th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $38.33 (+39.9%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, QDEL is in a strong downtrend. Immediate support is located at $25.81, while resistance sits at $35.58.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. In the options market, Implied Volatility is low (6th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $38.33 (+39.9%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
OVERSOLD
Fair Price Range
$27.98 -
$33.01
Company Quality Score
55/100
(HOLD)
Options IV Signal
6th percentile
(COMPLACENCY WARNING)
Volume Confirmation
HIGH
Confidence Score
83.5%
All Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Options cheap (IV 6th percentile)
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 39.9% below Wall St target ($38.33)
Fair Price Analysis
30-Day Fair Range
$27.98 -
$33.01
Current vs Fair Value
OVERSOLD
Expected Move (7 Days)
±$2.94
(10.8%)
Support & Resistance Levels
Support Level
$25.81
Resistance Level
$35.58
Current Trend
Strong Downtrend
Fundamental Context
Forward P/E (Next Year Est.)
10.94
Wall Street Target
$38.33
(+39.9%)
Revenue Growth (YoY)
-3.7%
Earnings Growth (YoY)
-77.1%
Profit Margin
-43.5%
Valuation Discount vs History
-2.1% cheaper
PE vs Historical
10.9 vs 11.6
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-2.1%
(market-implied from PE analysis)
1-Year Target
$26.83
(-2%)
2-Year Target
$26.27
(-4%)
3-Year Target
$25.72
(-6%)
3-Yr Target (if PE normalizes)
(PE: 11→12)
$27.28
(-1%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 22.3, Growth: 20.6%)
$98.02
(+258%)
Base:
(SPY PE: 10.9, Growth: 20.6%)
$48.07
(+75%)
Bear:
(PE: 9.3, Growth: 20.6%)
$40.86
(+49%)
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 10.9 to 11.6
Stabilization Target:
$29.08
(+6.1%)
PE Expansion Potential:
+6.1%
Last updated: January 30, 2026 5:41 PM ET
Data refreshes hourly during market hours. Next update: 6:41 PM
Data refreshes hourly during market hours. Next update: 6:41 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is QDEL showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
SYK
Stryker Corporation |
BUY
32 analysts |
$427 | 68 BUY |
|
DXCM
DexCom Inc |
STRONG BUY
26 analysts |
$85 | 65 BUY |
|
ABT
Abbott Laboratories |
BUY
28 analysts |
$136 | 63 BUY |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$110 | 63 BUY |
|
EW
Edwards Lifesciences Corp |
HOLD
32 analysts |
$97 | 59 HOLD |
Advanced QDEL Option Strategies
Professional options setups generated by AI based on today's QDEL price and gamma walls.
